INTRODUCTION
============

During cell proliferation, maintenance of the integrity of the genome is of paramount importance. For this reason, multiple cell cycle checkpoints assure the proper completion of preceding stages of the cell cycle before the next stage ensues. These regulatory mechanisms protect cells from the consequences of DNA damage, premature termination of DNA replication, and progression into anaphase before chromosomes are properly aligned and under tension at the metaphase plate.

Of equal importance to preservation of euploidy, cells must properly complete cytokinesis to ensure correct distribution of chromatin to daughter cells. Despite these controls, aneuploidy and chromosomal instability are characteristic of the great majority of human cancers ([@B11]) and are linked to the progressive development of high-grade, invasive tumors ([@B65]; [@B60]; [@B30]).

Tetraploidy---the inheritance of twice the normal number of chromosomes---can arise as a result of pathological processes such as chromosome nondisjunction ([@B75]), telomere dysfunction ([@B17]; [@B16]), adenomatous polyposis coli (APC) mutation ([@B12]), or abnormal cell fusion ([@B21]). Because tetraploid cells inherit twice the normal complement of centrosomes ([@B9]; [@B42]; [@B59]), they can rapidly proceed to aneuploidy by production of multipolar spindles at the next mitosis, with one centrosome at each spindle pole driving random chromosome segregation into aneuploid daughter cells ([@B3], [@B2]; [@B42]). Alternatively, if multiple centrosomes cluster to form a proper bipolar division ([@B9]; [@B45]; [@B36]; [@B38]), tetraploid cells may generate aneuploidy by exiting mitosis with lagging chromosomes ([@B26]).

A critical question is to what extent cells can control or suppress the cell cycle after cleavage failure. Although preservation of an intact genome is important to the organism, the extent to which tetraploid cells have the capacity to arrest remains unclear.

Several laboratories have found that nontransformed mammalian cells cease proliferating immediately after becoming tetraploid ([@B87]; [@B2]; [@B88]; [@B21]; [@B24]), whereas transformed cells continue cycling and proceed to aneuploidy ([@B2]; [@B21]). Our results showed that arrest induced by cleavage failure occurs immediately in G1 of the next cycle ([@B2]). Others found that nontransformed cells inefficiently arrest after cleavage failure ([@B82]; [@B75]; [@B35]). This disparity requires an explanation, which may lie in the molecular details of the G1 checkpoint machinery.

Although arrest in tetraploid G1 requires p53 ([@B2]; [@B24]), it is not strictly p53 dependent, as primary mouse embryo fibroblasts (MEFs) with intact p53 but with triple knockout of the Rb pocket protein family (pRb, p107, p130) escape tetraploid arrest ([@B9]; [@B40]). In accord with lack of strict dependence on p53 response, it appears that tetraploid arrest in G1 does not induce a DNA damage response ([@B24]). The capacity of cells to arrest in G1 when disruptions of mitosis or cell cleavage induce tetraploidy is potentially important to the control of tumor growth, as it represents the last opportunity for tetraploid cells to avoid aneuploidy.

Here we examine the induction of cell cycle arrest by cleavage failure in both rodent and human cell lines. Both rat and human primary cells arrest indefinitely in G1 immediately after induction of tetraploidy, and arrest occurs through the induction of senescence. The induction of senescence requires both p53 and pRb pathways and is particularly dependent on p16INK4a function ([@B8]), as suppression of p16INK4a permits bypass of tetraploidy arrest.

Assuming failure of cell cleavage induces senescence only in primary cells with intact p16INK4a or pRb function, our results predict that immortalized and transformed cells, which routinely suppress p16INK4a or pRb function ([@B55]; [@B19]; [@B8]) and are unable to enter senescence ([@B71]), are also unable to arrest when tetraploid.

Our work suggests that competence to become senescent is an absolute requirement for the prolonged arrest of primary tetraploid cells and that senescence invariantly follows induction of tetraploidy in primary cells but not in immortalized cells.

RESULTS
=======

Effect of cell cleavage failure on the cell cycle of primary and transformed cells
----------------------------------------------------------------------------------

Unsynchronized rat embryo fibroblast primary cells (REF52) and large SV-40 T-antigen transformed--REF52 variants (TAGs) were exposed to dihydroxycytochalasin B (DCB; [Figure 1](#F1){ref-type="fig"}), an inhibitor of actin assembly ([@B5]; [@B43]) that blocks mammalian cell cleavage at concentrations \>4 μM ([@B40]), or to blebbistatin, a myosin II inhibitor ([@B79]; [Figure 2](#F2){ref-type="fig"}). Both inhibitors effectively suppress cytokinesis, generating tetraploid cells. In our previous studies on tetraploidy, we used synchronous cell populations. The use of unsynchronized cells in the present work was designed to avoid any possible contribution of DNA damage ([@B86]; [@B83]; [@B27]) induced by synchronization before induction of tetraploid cell arrest.

![Response of REF52 and TAG cells to DCB-induced tetraploidy. Both REF52 (A) and TAG (B) cells were exposed to 10 μM DCB for 24 h and then released from DCB for the indicated times while remaining subconfluent. Cells were then harvested at the times shown and subjected to flow cytometry to follow DNA content (lower line plots) and BrdU incorporation (upper dot plots). DNA content marks indicate 2*N* unreplicated cells, 4*N* replicated cells, and 8*N* cells that have proceeded through another replication cycle after becoming tetraploid. Cells that do not align with the marks are aneuploid. BrdU arcs indicate DNA replication during 0.5-h exposure to BrdU. Microscopy images show microtubules (red) and DNA (DAPI, blue) in both nontreated (NT) cells and cells released from DCB for 48 h. Note binucleate REF52 and multinucleate TAG cells after DCB release. Scale bars, 40 μm.](3105fig1){#F1}

![Response of REF52 and TAG cells to blebbistatin-induced tetraploidy and of HFF to DCB-induced tetraploidy. (A) REF52 and TAG cells were exposed to the myosin II inhibitor blebbistatin (100 μM) for 24 h, as for DCB in [Figure 1](#F1){ref-type="fig"}, and then released from drug for the indicated times while remaining subconfluent. Flow cytometry shows DNA content. (B) HFF cells at low passage were exposed to 10 μM DCB for 48 h and then released for the indicated times. Flow cytometry plots show population distribution relative to DNA content, indicated as 2*N*, 4*N*, and 8*N*, where 8*N* represents tetraploid cells that have continued to cycle.](3105fig2){#F2}

Approximately half the initially asynchronous population had 4*N* DNA content after 24-h exposure to either DCB or blebbistatin, as analyzed by flow cytometry, whereas half had 2*N* DNA content ([Figures 1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}) as previously demonstrated ([@B40]). During drug treatment, REF52 did not incorporate 5-bromo-2'-deoxyuridine (BrdU; [Figure 1A](#F1){ref-type="fig"}), indicating lack of DNA synthesis. The persistent 2*N* peak and lack of DNA replication exist during DCB exposure because, as previously demonstrated, even minimal suppression of actin assembly induces a transient and reversible G1 (2*N*) arrest in primary fibroblasts ([@B40]). In contrast, untreated controls had a predominantly 2*N* profile and exhibited a robust BrdU arc between 2*N* and 4*N*, indicating active DNA replication.

On release from DCB, a BrdU arc reappeared between 2*N* and 4*N*, indicating restoration of the euploid cell cycle. In contrast, 4*N* cells were largely unable to proceed to 8*N* and showed little BrdU incorporation. The 4*N* population thus remained arrested after DCB release, whereas the transiently arrested 2*N* population reestablished the proliferating population. A small 8*N* peak appeared during the first 24 h of drug exposure, suggesting that an initial 4*N*-to-8*N* bypass created a small 8*N* subpopulation that did not go on to divide ([Figure 3](#F3){ref-type="fig"} and Supplemental Video S1). After DCB release, the population exhibited many binucleate cells not present before treatment ([Figure 1A](#F1){ref-type="fig"}, right).

![Quantitation of mitosis in mononucleate and binucleate cells. (A) REF52 cells were either untreated or exposed to 10 μM DCB for 24 h and then released from drug. Cells were then recorded by DeltaVision deconvolution video microscopy at 400×, and the number of cells undergoing mitosis relative to the total cells was counted from random field video recordings over a 24 h period. Mononucleate cells and binucleate cells were separately scored relative to the total cells of their respective classes. *N* ≥ 300 cells per lane. Values indicate the percentage of mononucleate or binucleate cells that divided in 24 h. Right, image captures from videos of DCB-treated and then released binucleate cells (top) and euploid controls (bottom). The euploid image includes two anaphases. (B) Ki-67, a cell proliferation marker, is specifically absent from binucleate cell nuclei. HFF were exposed to 10 μM DCB for 24 h and then released from drug. Mononucleate and binucleate cells were quantitated as Ki-67 positive or negative in three independent experiments. More than 300 mononucleate or binucleate cells were counted in each experiment. Results are expressed as mean ± SD. Representative IF image of anti--Ki-67 stain (green, enhanced green fluorescent protein secondary antibody) shows binucleate cells without Ki-67. DNA counterstain is DAPI. Scale bar, 40 μm.](3105fig3){#F3}

The outcome with blebbistatin ([Figure 2A](#F2){ref-type="fig"}) was comparable in detail to results with DCB. During drug treatment, many 2*N* cells did not proceed in the cell cycle, whereas the rest failed in cleavage and accumulated as a 4*N* population. The transient 2*N* arrest with either DCB or blebbistatin suggests that suppressed lamellipodial motility, rather than suppression of actin assembly per se, induced euploid G1 cell cycle arrest in nontransformed cells ([@B14]). These results contrast with the claim that blebbistatin does not induce transient G1 arrest in euploid primary cells ([@B35]). The increasing prominence of the 2*N* peak during recovery indicates that the transiently arrested 2*N* cells recover and reestablish a euploid population.

Primary human foreskin fibroblasts (HFFs) at low passage responded to DCB ([Figure 2B](#F2){ref-type="fig"}) in a manner that paralleled the response of low-passage REF52 cells ([@B40]). In HFF cells plated on fibronectin and treated with DCB, a predominantly 2*N* euploid population was restored 7 d after release from DCB. The 4*N* population remained arrested, as ungated flow cytometry indicated that few cells had \>4*N* DNA content at this time, and the absence of a \<2*N* population in ungated flow cytometry indicated no appreciable cell death.

Video recordings of primary cells released from DCB after 24-h exposure and recorded in the first 24 h of recovery indicate that binucleate cells are abundant. Although the cells are healthy and motile, they do not undergo mitosis (Supplemental Video S1). Of importance, video recordings were done in the absence of blue light, known to interfere with cell cycle progression ([@B82]). In striking contrast, untreated controls exhibit many mitotic events in the same time course (Supplemental Video S2), confirming that recording conditions do not inhibit mitosis. The cells used in all our experiments were grown on a lawn of fibronectin to determine whether it modifies the induction of tetraploid arrest ([@B82]). We found no notable effect of fibronectin on the outcome compared with growth on poly-[d]{.smallcaps}-lysine--coated surfaces. Quantitation of the percentage of cells undergoing mitosis, from multiple videos, confirmed that virtually no binucleate cells underwent division during 24 h of recovery from DCB, in contrast to mononucleate cells in the same culture dishes ([Figure 3A](#F3){ref-type="fig"}).

To confirm that binucleate cells were not cycling, we exposed HFF to DCB for 24 h, released them from DCB for 24 h, and then stained them for Ki-67 nuclear antigen, a proliferation marker ([@B67]). In the mixed population of mononucleate and binucleate cells on the same slide, Ki-67 was specifically absent from the nuclei of binucleate cells, whereas it gave a strong positive signal in mononucleate cell nuclei ([Figure 3B](#F3){ref-type="fig"}).

TAG cells responded to DCB in a notably different manner than primary REF52 or HFF cells. After 24 h exposure to drug, there was no 2*N* G1 subpopulation, and the cells predominantly exhibited 4*N*-to-8*N* DNA content, with a prominent 8*N* peak ([Figure 1B](#F1){ref-type="fig"}). At 24 and 48 h of release from DCB, the transformed cells were actively proliferating and increasingly aneuploid. Microscopic images of treated cells confirm the flow cytometry data, indicating that TAG cells, unlike REF52, became multinucleate and highly aneuploid after release from DCB ([Figure 1B](#F1){ref-type="fig"}). Similarly, TAG cells became highly aneuploid within 24 h of release from blebbistatin ([Figure 2A](#F2){ref-type="fig"}).

To confirm that cell cycle arrest of primary tetraploid cells was not a nonspecific consequence of drug exposure, we suppressed cell cleavage in REF52 and TAG cells by small interfering RNA (siRNA) targeting of two proteins required for cytokinesis, protein required for cytokinesis 1 (PRC1; [@B48]) and anillin ([@B54]). Western blots confirmed that knockdown was effective at 24 and 48 h posttransfection ([Figure 4A](#F4){ref-type="fig"}). By 48 h, REF52 that were transfected with siRNA to PRC1 or anillin had largely accumulated at 4*N*, whereas identically treated TAG cells had largely proceeded to 8*N* ([Figure 4B](#F4){ref-type="fig"}). Immunofluorescence assays showed a substantial accumulation of binucleate cells at 48 h ([Figure 4C](#F4){ref-type="fig"}), as was also evident in wide-angle anti-tubulin images of control and PRC1 siRNA--treated cells (Supplemental Figure S2). Quantitation of results from several microscopic assays confirmed that the REF52 population accumulated little BrdU, whereas TAG cells were substantially positive ([Figure 4D](#F4){ref-type="fig"}), confirming that primary cells made tetraploid by siRNA suppression of cell cleavage did not undergo DNA replication, whereas TAG cells did.

![REF52 cells arrest in tetraploid G1 after PRC1 or anillin ablation. (A) Western blots confirm that either PRC1 or anillin had been effectively depleted at 24 and 48 h after siRNA transfection. Actin is a loading control. Extracts from each experimental condition were run on the same gel, but gel lanes were not contiguous, as indicated by separations. (B) At 48 h after siRNA ablation of PRC1 (top) or anillin (bottom), REF52 largely accumulated at 4*N*, whereas identically treated TAG cells substantially proceeded to 8*N*. (C) Immunofluorescence of BrdU incorporation into REF52 and TAG cells transfected with siRNA to PRC1. In both cases, binucleate cells are abundant. Both REF52 and TAG were recorded at identical microscope settings. Only TAG cells incorporated BrdU after becoming binucleate. DNA was stained with propidium iodide. Scale bar, 50 μm. (D) Microscopic quantitation of BrdU incorporation into binucleate cells after PRC1 or anillin knockdown. Cells were transfected with siRNA to PRC1 or anillin, and the binucleate cells were quantitated at 48 h for BrdU incorporation. Binucleate REF52 show little BrdU incorporation, whereas binucleate TAG cells are highly positive for BrdU. Graphs are averages from three different assays for each condition. Results are expressed as mean ± SD.](3105fig4){#F4}

As a further confirmation that tetraploid primary cells are unable to cycle, we used a fluorescent ubiquitination-based cell cycle indicator (FUCCI) expression assay to assess the cell cycle distribution of HFF cells 48 h after release from DCB-induced tetraploidy. The FUCCI assay ([@B63]) uses lentivirus vector coexpression of mAG-hGem, a green fluorescent marker for geminin expression, which is specific to the G2/M phase of the cell cycle, and of mKO2-hCdt1, an orange-red fluorescent marker for Cdt1 expression, which is specific to the G0/G1 phase of the cell cycle. Results confirm that binucleate tetraploid HFFs were uniformly in G0/G1, whereas mononucleate euploid cells in the same dishes were in both early and late phases of the cell cycle ([Figure 5, A and B](#F5){ref-type="fig"}).

![Binucleate primary cells lose G2/M markers. (A) HFF cells were transfected with lentivirus expressing fluorescent geminin and hCdt1 (chromatin licensing and DNA replication factor 1), markers for G2/M and G1, respectively. After ascertaining that the cells were fluorescent, cells were exposed to 10 μM DCB for 24 h and then were recorded for 24 h after drug release. Video images from DeltaVision microscope recordings were quantitated for cells positive for geminin or hCdt1 markers. In the same culture chamber, mononucleate cells were positive for the G2/M geminin marker, while binucleate cells were negative. Both populations were positive for hCdt1. Data are composite from three independent experiments. Right, microscopy images show geminin (green) mononucleate cells and an hCdt1 (orange) positive binucleate cell. Scale bar, 40 μm. (B) Tetraploid REF52 cells lose late cell cycle markers. REF52 and TAG cells were exposed to 10 μM DCB for 24 h, released for 6 h, and then exposed again to DCB for 24 h to maximize REF52 tetraploidy. Western blots of cell extracts taken at the indicated times after final drug release show that REF52 cells have lost Aurora B and cyclin B by 48 h of release, whereas TAG cells continue to express these late-cell-cycle proteins. α-Tubulin serves as a loading control. NT gel lanes were from the same gel as treated samples, but they were not contiguous, as indicated by separations.](3105fig5){#F5}

Consistent with FUCCI and Ki-67 results, Western blots of two late-cell-cycle markers, Aurora B and cyclin B1, indicated that late-cell-cycle markers were greatly diminished by 48 h of release from DCB-induced tetraploidy in REF52 cells but remained present in paired large T-antigen--transformed TAG cells ([Figure 5C](#F5){ref-type="fig"}).

Failure of cell cleavage should not affect the integrity of the genome, which segregates without error during mitosis before cleavage failure. There was, indeed, no evidence for DNA damage in tetraploid G1-arrested cells, as indicated by analysis of the DNA damage marker phosphorylated histone 2 variant H2AX ([@B57]) in tetraploid nuclei ([Figure 6](#F6){ref-type="fig"}). The signal strength of γ-H2AX foci in nuclei closely matched that of controls ([Figure 6A](#F6){ref-type="fig"}), as did the average number of foci per nucleus ([Figure 6B](#F6){ref-type="fig"}). For these experiments, the microscope gain was set high in order to capture any positive foci in controls or DCB-treated cells, yielding a background signal in both conditions. By contrast, a modest level of γ-irradiation yielded abundant H2AX phosphorylation ([Figure 6, A and B](#F6){ref-type="fig"}). In accord with these results, the Ser-15 residue, phosphorylated on p53 in response to DNA damage ([@B29]), was not phosphorylated in DCB-treated HFF cells ([Figure 6C](#F6){ref-type="fig"}). For comparison we show the phosphorylation of Ser-15 on p53 in response to DNA damage induced by exposure to Adriamycin. Similarly, tetraploidy does not provoke another response to DNA damage---phosphorylation of checkpoint kinase 2 (Chk2) on Thr-68 ([@B1]; [Figure 6C](#F6){ref-type="fig"}).

![Tetraploidy arrest does not involve DNA damage. (A) Both REF52 and TAG cells were exposed to 10 μM DCB for 24 h and then released for 24 h and stained for γ-H2AX, a marker for cell response to DNA damage ([@B57]). The counterstain for DNA is DAPI. Binucleate cells of either cell type show no intense DNA damage response. γ-Irradiation (4Gy) of REF52 and TAG cells serves as a positive control. All images were taken from the same experiment, using identical image capture settings. (B) Quantitation of the number of γ-H2AX foci present in nuclei, visualized with microscopy, using procedures detailed in *Materials and Methods*. All foci that were above a set intensity threshold were automatically counted. The intensity of foci in irradiated nuclei was substantially greater than in other conditions, as seen in A. Results are expressed as mean ± SD. Foci within at least 100 nuclei were counted in each condition. (C) Western blot of DNA-damage markers in HFF cells, phospho-Ser-15 p53, and phospho-Thr-68 Chk2, demonstrating that these markers are not elevated after tetraploidy induction by two rounds of 10 μM DCB treatment compared with control random cycling cells. Adriamycin induction of DNA damage 72 h after drug treatment is the positive control for DNA damage response (Adr). Actin is a loading control.](3105fig6){#F6}

Because we avoided synchronization procedures earlier in the cell cycle that might initiate a DNA damage response ([@B86]; [@B83]; [@B27]), these results show that failure in the completion of cytokinesis does not, in itself, provoke DNA damage.

Primary tetraploid cells become senescent
-----------------------------------------

Our results demonstrate that REF52 and HFF primary cells arrest in G0/G1 when tetraploid and that the failure to reenter the cell cycle is stable. This status suggests that the cells have permanently lost the capacity to proliferate and therefore become senescent. To confirm continuing quiescence, we assayed tetraploid cells for the persistence of primary cilia, a marker of cell quiescence ([@B81]; [@B58]; [@B28]). To assess the induction of senescence, we assayed for expression of a well-established cell senescence marker, senescence-associated β-galactosidase (SA-β-gal), an enzyme activity associated with the senescent phenotype ([@B20]).

Nontransformed cells in culture assemble primary cilia during cell cycle exit, and disassembly occurs during cell cycle reentry ([@B69]). Tubulin acetylation is required for stability of primary cilia and serves as a marker ([@B58]). Acetylated tubulin--stained primary cilia were evident in mononucleate serum-starved HFF cells and in mononucleate cells in the presence of DCB ([Figure 7A](#F7){ref-type="fig"}), indicating G1 quiescence in the presence of the drug. After release from DCB, the mononucleate HFF cells reverted to control levels. Binucleate cells, also positive during exposure to DCB, remained ciliated 72 h after DCB release, indicating a sustained G0 block ([Figure 7A](#F7){ref-type="fig"}). Images show representative ciliated binucleate HFF cells ([Figure 7A](#F7){ref-type="fig"}).

![Tetraploid HFFs express quiescence and senescence markers. (A) Primary cilia, markers of cell quiescence, become abundant in HFF cells that have been exposed to 10 μM DCB for 24 h (DCB treated), indicating quiescence of both mononucleate and binucleate cells. By 72 h of release from DCB, the transiently arrested mononucleate population returns to nontreated (NT) levels, whereas the binucleate population remains ciliated. Serum-starved G0 HFFs serve as a positive control. Right, immunofluorescence of primary cilia in binucleate HFF cells, visualized with antibody to acetylated α-tubulin (green; [@B58]). Counterstains were total α-tubulin (red) and DNA (DAPI, blue). Scale bar, 20 μm. (B) Tetraploid HFFs are positive for SA-β-galactosidase by 3 d after release from DCB. HFFs were treated with 10 μM DCB for 24 h and released. Cells were harvested and assayed for SA-β-gal activity at time points indicated. The percentage SA-β-gal--positive binucleate cells was quantitated in three independent experiments. Results are expressed as mean ± SD. Right, images of binucleate cells stained for SA-β-gal activity at 3 d of release compared with untreated controls. Scale bar, 40 μm.](3105fig7){#F7}

When assayed for the level of expression of SA-β-gal, HFF cells exposed to DCB and released for 3 d were increasingly SA-β-gal positive ([Figure 7B](#F7){ref-type="fig"}), indicating induction of senescence. An image enlargement shows that positive cells are binucleate (Supplemental Figure S1).

After tetraploid arrest, primary cells exhibit senescence markers characteristic of Raf-induced senescence
----------------------------------------------------------------------------------------------------------

Oncogenic Ras and Raf transform immortalized cells but cause primary cells to instead enter premature senescence ([@B39]; [@B89]; [@B44]). The induction of premature senescence by oncogenic Ras or Raf is accompanied by characteristic protein changes, including high levels of extracellular signal-regulated kinase (ERK) 1/2 phosphorylation and elevated expression of G1 cyclin D1 ([@B89]). Induction of tetraploidy in primary cells has a similar effect, causing ERK1/2 to become highly phosphorylated at MEK substrate residues ([Figure 8A](#F8){ref-type="fig"}). Senescence induced by oncogenic Raf in primary cells also drives expression of cyclin D1 ([@B89]), and cyclin D1 is elevated in primary cells that have been made tetraploid ([Figure 8A](#F8){ref-type="fig"}), in contrast to contact-inhibited cells, which show little cyclin D1 expression. For these experiments, cells were doubly exposed to DCB to enrich for a 4*N* quiescent population, as described in *Materials and Methods*.

![Changes in protein expression in tetraploid arrest. (A) HFF cells were exposed to 10 μM DCB for 24 h, released for 6 h, and then exposed again to DCB for 24 h to maximize tetraploidy. Extracts were harvested for assay 2 d after DCB release. ERK1/2 is highly phosphorylated (p-ERK1/2), and cells have a high level of cyclin D expression. There is no increase in ERK1/2 expression. Results were compared with contact-inhibited (CI) and random cycling controls. Samples are from the same extracts, and tubulin is a loading control. (B) Immunofluorescence of cells treated as in A shows that phospho-ERK (p-ERK) is perinuclear and intranuclear in binucleate cells. Counterstains are propidium iodide for DNA and anti--α-tubulin antibody. Scale bar, 40 μm. (C) HFF cells, doubly exposed to DCB as in A, were assayed at the times indicated after release and compared with CI and random cycling controls (--). DCB-treated cells were positive for p21waf1 and p27kip1. Tubulin is a loading control. (D) Western blot showing that tetraploidy induces expression of p16INK4a at 3 d after transfection of HFF cells with PRC1 siRNA or 2 d after release from 10 μM DCB (DCB release). Controls are cells transfected with scrambled siRNA or cells not treated with DCB. The DCB lane indicates a sample taken after 24 h in 10 μM DCB. Tubulin is a loading control. Bottom, microscope images show HFF cells released from 10 μM DCB for 24 h and stained for p16INK4a (green) and DNA (blue, DAPI). Binucleate cells are positive for p16INK4a, and mononucleate cells are negative. Microscope settings were constant for all images. Scale bars, 40 μm.](3105fig8){#F8}

Phosphorylated ERK2 localizes both within the nucleus and in the perinuclear space ([Figure 8B](#F8){ref-type="fig"}). As reported for Raf-induced senescence ([@B89]), inhibition of ERK phosphorylation by exposure to the MEK inhibitor UO126 does not reverse tetraploidy-induced senescence (unpublished data). The molecular response to tetraploidy-induced senescence is therefore similar to that induced by oncogenic Raf.

Further, we found that the cell cycle arrest markers p21waf1 and p27kip1 become elevated in primary cells after release from DCB and remain persistent ([Figure 8C](#F8){ref-type="fig"}). Elevated p21waf1 is also evident after induction of senescence in primary cells by oncogenic Raf ([@B89]), and p27kip1 expression has been reported to suppress polyploidy after cleavage failure ([@B73]).

Dual control of tetraploidy arrest through p53 and p16INK4a
-----------------------------------------------------------

The activation of premature senescence in primary cells by Raf expression is regulated by both p53 and p16INK4a ([@B89]), and p16INK4a is generally important to the induction of replicative senescence ([@B13]). Although sustained arrest of primary tetraploid cells requires p53 ([@B2]; [@B24]; [@B70]; [@B84]), Rb controls are also evidently involved in regulating tetraploidy arrest. Consistent with a role for p16INK4a, which controls the Rb pathway ([@B74]), we previously showed that triple knockout of pRb, p107, and p130 abrogates cell cycle arrest induced by tetraploidy in primary MEFs ([@B9]). p16INK4a, which is required for onset of senescence and is considered a senescence marker ([@B61]; [@B64]), is induced in primary cells made tetraploid by either transfection of siRNA to PRC1 or exposure to DCB ([Figure 8D](#F8){ref-type="fig"}). Induction of p16INK4a arises with a short time lag after exposure to DCB, as found previously for p16INK4a induction after DNA damage ([@B62]; [@B33]). Immunofluorescence shows strong p16INK4a labeling in DCB-treated binucleate cells, whereas mononucleate cells have only background stain ([Figure 8D](#F8){ref-type="fig"}).

To demonstrate a dual requirement for p53 and p16INK4a in the induction of senescence by tetraploidy, we assayed p53-competent HCT116 colon carcinoma cells. We found that HCT116 did not arrest when made tetraploid but continued first to 8*N* and then to aneuploidy ([Figure 9A](#F9){ref-type="fig"}). In fact, p53^+/+^ HCT116 colon carcinoma cells continued to proliferate at the same pace as p53^−*/*−^ HCT116 ([Figure 9B](#F9){ref-type="fig"}). In contrast, exposure of the same cells to the DNA damage agent Adriamycin effectively blocked proliferation. Of importance, although HCT116 cells express wild-type p53, they do not express p16INK4a ([@B49]). These results indicate that expression of intact p53 is not sufficient to induce arrest in tetraploid cells.

![Treatment with DCB does not arrest HCT116 p53^+/+^ cell proliferation. (A) HCT116 p53^+/+^ cells were treated with 10 μM DCB for 24 h and then released for the indicated times. The HCT116 cells proceed from tetraploidy to aneuploidy during 72 h of release. (B) HCT116 p53^+/+^ and HCT116 p53^−*/*−^ were exposed to 10 μM DCB or 2 μg/ml Adriamycin ([@B76]) for 24 h and then released. Cell counts were then performed at the indicated times. Cells continue to proliferate when tetraploid and aneuploid, regardless of p53 status, but do not recover from Adriamycin.](3105fig9){#F9}

To test directly the importance of p16INK4a in tetraploidy arrest, we transfected HFFs with siRNA to p16INK4a and 48 h later exposed the cells to DCB for 24 h. After siRNA suppression of p16INK4a, tetraploid HFF cells did not remain arrested in G1 but continued to cycle, creating a prominent 8*N* population ([Figure 10](#F10){ref-type="fig"}) and evident induction of aneuploidy. Both euploid and tetraploid cells exhibited extensive incorporation of BrdU. Control treatment with scrambled siRNA yielded a cell distribution like that shown for HFF cells treated with DCB ([Figure 2](#F2){ref-type="fig"}). The result demonstrates that the capacity to arrest in G1 when tetraploid depends on an intact p16INK4a response and that its activation is thus one of the components required for the induction of senescence in response to the onset of tetraploidy in primary cells.

![Suppression of p16INK4a abrogates tetraploid arrest of HFF cells. (A) HFFs were transfected with siRNA to p16INK4a, exposed to 10 μM DCB for 48 h, and then assayed with flow cytometry. p16INK4a siRNA--transfected cells accumulated at 2*N* and 4*N* during DCB treatment. By 48 h of release from DCB, p16INK4a siRNA suppression substantially abrogated tetraploid arrest, and both euploid and tetraploid siRNA-transfected HFF cells were positive for BrdU incorporation (dot plot). (B) HFF cells transfected with scrambled siRNA as a control, treated as described with DCB, and assayed with flow cytometry.](3105fig10){#F10}

DISCUSSION
==========

The importance of tetraploidy arrest
------------------------------------

Tetraploidy---the presence of twice the normal number of chromosomes---is an ominous state in mammalian tissues. In many human carcinomas, cells with tetraploid DNA content arise as an early step in tumorigenesis that precedes the formation of aneuploid cells ([@B42]; [@B68]; [@B77]). Aneuploidy and chromosomal instability in turn are characteristic of the great majority of human cancers ([@B11]) and are linked to the progressive development of high-grade, invasive tumors. Aneuploidy can arise from tetraploid cells, regardless of whether subsequent cell divisions are bipolar or multipolar. We previously showed that cells competent to continue cycling when tetraploid either proceed to a multipolar mitosis with separated spindle poles ([@B9]) or, with nearly equal likelihood, cluster their centrosomes to create a bipolar spindle ([@B9]). Gross aneuploidy results from multipolar spindle mitosis, but tetraploid cells proceeding through bipolar mitosis with clustered centrosomes are prone to induction of aneuploidy through improper merotelic chromosome attachments and chromosome loss in anaphase ([@B25]). Flow cytometry confirms that continued cycling of tetraploid TAG and HCT116 p53^+/+^ cells creates a mixture of tetraploid and highly aneuploid daughter cells ([Figures 1](#F1){ref-type="fig"}, [2](#F2){ref-type="fig"}, and [10](#F10){ref-type="fig"}).

Tetraploidy can arise through any of several mitotic errors, including chromosome nondisjunction ([@B75]), mitotic slippage ([@B46]; [@B37]; [@B10]), as a result of critically short telomeres ([@B16]), or through cleavage failure consequent to aberrant expression of APC ([@B12]), LATS1/2 ([@B31]; [@B6]), or BRCA1 ([@B66]). Although many tetraploid-transformed cells that become aneuploid may die, the survivors can acquire either favorable mutations or chromosome profiles, with consequences for tumor development.

The presence of prolonged tetraploidy before aneuploidy is of central importance to cancer progression in multiple tumor types ([@B15]). It has therefore been an important but unresolved issue whether euploid nontransformed cells have mechanisms to prevent tetraploid proliferation and induction of aneuploidy, and it is important to understand how tumor cells evade these controls. The existence of controls that can arrest nontransformed tetraploid cells has been considered controversial due to reports that nontransformed tetraploid cells only partially arrest ([@B82]; [@B75]; [@B35]) or that tetraploid arrest is attributable to DNA damage induced by experimental manipulation ([@B86]). In contrast, several laboratories reported that nontransformed mammalian cells cease proliferating immediately after becoming tetraploid ([@B87]; [@B2]; [@B88]; [@B21]; [@B24]). We believe that the present study, demonstrating induction of senescence in tetraploid primary cells, offers a resolution of these disparate results.

The question arises of why our results are at variance from those of the Sluder laboratory ([@B82]; [@B35]). Given the repeated demonstration by several laboratories that nontransformed cells rapidly arrest when tetraploid ([@B87]; [@B2]; [@B88]; [@B21]; [@B24]) and the observation that hTERT immortalized cells only partially arrest ([@B75]), we propose that the critical difference may be that cells must be competent to senesce in order to arrest in tetraploid state and that hTERT immortalized cells have suppressed the p16INK4a response and do not senesce ([@B19]; [@B53]). We note that the work from the Sluder laboratory showing tetraploid bypass in nontransformed cells used hTERT-RPE1 cells for a substantial part of one study ([@B82]) and hTERT-RPE1 for all the nontransformed cells in another ([@B35]).

The requirement for primary cell status in tetraploidy arrest
-------------------------------------------------------------

Senescence is defined as the persistent arrest of cell proliferation in the presence of nutrients ([@B39]; [@B89]), and induction of senescence requires the intact function of both the p53 and pRb pathways ([@B39]). Tetraploid primary fibroblasts subjected to fluorescence-activated cell sorting cannot proliferate, whereas sorted diploid cells from the same population can ([@B24]). In contrast, hTERT-1 human fibroblasts, immortalized by hTERT expression, continue to cycle when tetraploid ([@B75]). hTERT-1 cells lack functional p16INK4a, a key protein in the activation of the pRb response ([@B19]). In general, suppression of p16INK4a is critical to immortalization of hTERT-expressing cells ([@B34]; [@B19]).

Primary REF52 cells arrest in tetraploid G1 after DCB exposure, whereas p53 mutant and large T-antigen--transformed REF52 continue cycling ([@B2]). Further, wild-type mouse epithelial cells do not proliferate when tetraploid ([@B70]), whereas p53-deficient cells continue to cycle ([@B84]). Suppression of survivin triggers cell cleavage failure, causing primary IMR-90 and RPE cells to arrest in tetraploid G1, but p53 depletion abrogates the arrest and drives endoreduplication ([@B88]). However, it is also clear that suppression of the pRb pocket proteins is sufficient to abrogate tetraploid arrest in p53-competent cells, as mouse embryo fibroblasts lacking pRb, p107, and p130 but wild type for p53 fail to arrest when they spontaneously become tetraploid ([@B9]) or become tetraploid after drug induction ([@B40]).

Tetraploidy controls in the organism
------------------------------------

Tetraploidy is normally incompatible with mammalian embryonic development. In a routine technique, mutant mice are produced by mixture of diploid and tetraploid cells to form a chimeric blastocyst. In resulting embryos, the tetraploid cells are restricted to extraembryonic tissue, whereas the epiblast becomes entirely euploid ([@B50], [@B51]; [@B22]). Thus tolerance of tetraploidy is limited to specific extraembryonic cells. Exceptions exist in both mice and humans ([@B26]), but the vast majority of embryos eliminate polyploid cells during early development ([@B51]). Given our results with p16INK4a, it is noteworthy that tetraploid cells persist in the epiblast until gastrulation in mouse ([@B41]), coincident with the time when pRb-dependent G1 controls initiate ([@B23]). Although certain adult mammalian cell types become tetraploid or polyploid during terminal differentiation ([@B26]), the absence of tetraploidy is the rule in conti­nuously replicating cells, likely due to specific constraints, the molecular nature of which remains to be determined.

Senescence induction without DNA damage
---------------------------------------

A distinction of the present study from our previous work on tetraploidy lies in the avoidance of cell synchronization steps before induction of tetraploidy, by either drug or siRNA suppression of critical cell cleavage proteins. In this way, we avoided cell presynchronization, which has been critiqued as a possible cause of DNA damage, a possible alternative trigger for the arrest of tetraploid cells ([@B86]). In this study, we find no evidence for a DNA damage response in tetraploid cells, as confirmed by the absence of phosphorylated histone H2AX, phospho-Ser-15 p53, or phospho-Thr-68 Chk2.

Indeed, with respect to the absence of DNA damage, the senescence induced by tetraploidy appears to be distinct from the majority of other premature senescence mechanisms. In contrast to tetraploidy-induced senescence, premature senescence in response to oncogene activation or critically short telomeres is preceded by a period of hyperproliferation and accumulation of DNA damage, accompanied by a robust DNA damage checkpoint response ([@B80]; [@B7]; [@B18]; [@B52]), which is followed by late onset of senescence. In fact, premature senescence has been characterized as a DNA damage response ([@B85]; [@B18]).

In contrast, senescence induction in response to Raf or Ras overexpression in nontransformed cells ([@B71], [@B72]; [@B89]) resembles the tetraploidy response. Both involve ERK1/2 phosphorylation and cyclin D1 overexpression in the absence of proliferation, and both occur only in primary cells. Further parallels include the rapid onset of senescence (within 3 d after induction), a requirement for the parallel function of p16INK4a and p21waf1, and the absence of a DNA damage response during activation ([@B32]). In the broader picture, induction of senescence in the absence of DNA damage occurs as an essential part of organism patterning during embryogenesis ([@B78]). It will be of great interest to address whether there are common mechanisms that underlie induction of senescence without DNA damage in nontransformed cells, either in the course of normal development or as a result of becoming tetraploid.

MATERIALS AND METHODS
=====================

Cell culture
------------

HFFs (Hs-27) were obtained from the stem cell core facility at the Sanford-Burnham Institute (La Jolla, CA) and were used at passages 9--11. HCT116 p53^+*/*+^ and p53^−*/*−^cells were the kind gift of Bert Vogelstein (Johns Hopkins Medicine, Baltimore, MD). Rat primary REF52 and TAG cell lines were as reported previously ([@B2]). REF52 were used at passages 18--20.

HFF, REF52, and TAG cell lines were grown as a monolayer in DMEM (Mediatech, Manassas, VA) supplemented with 10% fetal bovine serum (Hyclone, Logan, UT) and maintained in a humid incubator at 37°C in a 5% CO~2~ environment. HCT116 was grown in McCoy\'s 5A medium (Life Technologies, Carlsbad, CA) with 10% fetal bovine serum and maintained as described.

Drugs used to suppress cytokinesis were the myosin II inhibitor blebbistatin (100 μM; [@B79]) and DCB (10 μM), which were added to cell culture from 100× stocks in dimethyl sulfoxide, filtered for sterility, and kept frozen until use. The concentration of DCB used (10 μM) was the lowest concentration that completely suppresses cytokinesis, in our experience ([@B40]). Cytochalasin D, also used for tetraploidy analysis ([@B82]), suppresses cytokinesis at an eightfold lower concentration than DCB ([@B4]). We routinely used DCB to avoid secondary effects on glucose metabolism ([@B4]).

Double DCB synchronization of HFF cells
---------------------------------------

To obtain highly synchronous 4*N* HFF cells, randomly cycling cells were exposed to 10 μM DCB for 24 h, released for 6 h, exposed to DCB again for 24 h, and then released and harvested at indicated times for assays.

Flow cytometry
--------------

For flow cytometry, cells were harvested using trypsin-EDTA and centrifuged at 500 × *g* for 5 min at room temperature. The supernatant was aspirated and cells were trypsinized, washed, and fixed in −20ºC methanol for a minimum of 20 min and stored at −20ºC until time of staining. For analysis, cells were washed with 1× phosphate-buffered saline (PBS), stained with a propidium iodide (PI) solution (0.1% Triton X-100, 200 μg/ml DNase-free RNase A, and 3.0 μM PI), and analyzed on a Becton-Dickinson Excalibur flow cytometer using FloJo software (Ashland, OR). For BrdU incorporation, medium was removed from cells and replaced with fresh, warm medium containing 10 μM BrdU (B5002; Sigma-Aldrich, St. Louis, MO), and incubated for 1 h. Cells were then fixed and prepared for flow cytometry. For BrdU staining, fixed cells were prepared for PI stain and additionally incubated with fluorescein isothiocyanate (FITC)--conjugated anti-BrdU antibody (Becton Dickinson, San Jose, CA) as previously described ([@B2]).

Immunofluorescence microscopy
-----------------------------

For immunofluorescence (IF), cells were grown on fibronectin-coated (20 μg/ml human foreskin fibroblast fibronectin \[F2518; Sigma-Aldrich\]) coverslips. For fixation, coverslips were washed and exposed to 4% paraformaldehyde/PBS at room temperature. After fixation, coverslips were washed three times and blocked for 1 h in blocking buffer (0.3% Triton X-100, 5% normal goat serum diluted in PBS). Primary antibodies in 0.3% Triton X-100 and 1% bovine serum albumin in PBS were incubated on coverslips at 4ºC overnight in a humid chamber. Coverslips were then washed three times in PBS, and secondary antibodies were added and incubated for 1 h at room temperature. Coverslips were then washed once and incubated in antibody dilution buffer containing 4′,6-diamidino-2-phenylindole (DAPI) or PI for 10 min at room temperature. Coverslips were then washed three times in PBS, dipped briefly in double-distilled H~2~O, air-dried, and mounted with Clarion mounting medium. Images were taken using a DeltaVision deconvolution microscope equipped with an automated stage. A minimum of 15 0.2-μm *z*-sections were taken per field. Images were then deconvolved using softWoRx software (Applied Precision, Issaquah, WA). Where indicated, to stain DNA, DAPI (Life Technologies) was used at 300 nM and PI (Invitrogen) at 1.0 μM after DNase-free RNase pretreatment.

We used the softWoRx two-dimensional polygon tool for microscopic quantitation of γ-H2AX foci within each nucleus. The threshold was manually set so that overlaid polygons reflected single spots as they appeared to the eye. The threshold was then held constant for data capture of untreated, DCB-treated, and irradiated samples.

Primary cilia were quantitated by counting the percentage of total cells in random fields for the presence of cilia, as determined by anti--acetylated tubulin antibody stain, counting as positive all stained linear elements adjacent to nuclei.

Antibodies used for IF included anti--α-tubulin (B512; Sigma-Aldrich), anti--α-tubulin rat monoclonal antibody (mAb; YL1/2; ab6160; Abcam, Cambridge, UK), or anti--acetylated α-tubulin mouse mAb (clone 6-11B-1; Sigma-Aldrich), anti--phospho-ERK1/2 (anti--phospho-Thr-202/Tyr-204; 4377; Cell Signaling, Beverly, MA), anti--Ki-67 (rabbit mAb; 9129; Cell Signaling), anti-p16INK4a (mouse mAb 11104; Immuno-Biological Laboratories, Gunma, Japan), and anti--γ-H2AX (4411-PC; Trevigen, Gaithersburg, MD). Secondary fluorescent antibodies were from Cell Signaling.

Time-lapse microscopy
---------------------

For video microscopy, HFF, REF52, and TAG cell lines were seeded into four- or eight-chamber glass slides coated with 20 μg/ml fibronectin. For these experiments, we used L-15 medium for optimal buffering over prolonged periods. As appropriate, samples were exposed to 10 μM DCB for 24 h and then released from drug before video recording. At the time of release, slides were mounted on a Delta­Vision deconvolution microscope equipped with an automatic stage and CO~2~ and temperature control. Images were taken in the differential interference contrast (DIC) channel every 20 min, using the point revisit function, for up to 3 d, as described ([@B56]). A minimum of 10 fields were selected for each condition and experiment.

HFF cells infected with lentiviruses to express FUCCI markers were plated in four- or eight-chamber glass slides, exposed to 10 μM DCB, and then released into L-15 medium for video microscopy, and images were taken in the DIC, tetramethylrhodamine, and FITC channels every 20 min during a period of 24 h.

SA-β-galactosidase assay
------------------------

HFF cells were seeded on fibronectin-treated glass coverslips as described for IF. At the time of harvest, cells were washed once with PBS at room temperature and then fixed in 0.2% glutaraldehyde/PBS for 5 min. After fixation, coverslips were washed three times with PBS for 5 min each at room temperature. Coverslips were then stained for activity for 24 h at 37ºC in 0.1 mg/ml X-gal, 150 mM NaCl, 2 mM MgCl~2~, 5 mM K~3~Fe(CN)~6~, 5 mM K~4~Fe(CN)~6~, and 40 mM sodium phosphate, pH 6.0, and then imaged by phase contrast microscopy.

Treatment with siRNA targeting PRC1, anillin, and p16INK4a
----------------------------------------------------------

To target rat PRC1 and anillin, we used rat PRC1 and anillin siRNA from Dharmacon-GE (Lafayette, CO). For knockdown of PRC1 or anillin, cells were transfected 1 d after plating in 60-mm dishes when they displayed an estimated 40--45% confluency, and cells were collected for analysis 24 or 48 h after transfection. For BrdU analysis, cells were harvested 48 h after transfection and stained for BrdU incorporation as described.

To target p16INK4a, preverified siRNA and scrambled siRNA were obtained from Qiagen (Valencia, CA). Twenty-four hours after transfection, cells were exposed to 10 μM DCB for 24 h and then released for 48 h and assayed by flow cytometry. All siRNA transfections used 30 nM siRNA (final), introduced with Lipofectamine RNAiMax.

Immunoblotting
--------------

Cell lysates (25 μg**/**well) were resolved by PAGE, transferred to polyvinylidene fluoride membranes, and detected using chemiluminescence (Thermo Scientific Pierce, Rockford, IL). All primary antibodies were used at 1:1000. Appropriate secondary horseradish peroxidase--conjugated antibodies were used at 1:10,000. Antibodies used were p21waf1 (C-19; Santa Cruz Biotechnology, Dallas, TX), p27kip1 (610241; BD Transduction Lab, San Jose, CA), α-tubulin (B511; Sigma-Aldrich), anti-ERK1/2 (9102; Cell Signaling), anti--phospho-ERK1/2 (4377; Cell Signaling), anti--γ-H2AX (4411-PC; Trevigen), anti--cyclin D1/2 (05-362; Upstate Biotechnology, Lake Placid, NY), anti-anillin (C. Field, Harvard Medical School, Boston, MA; [@B54]), anti--phospho-Ser-15 p53 (12571; Cell Signaling), anti--phospho-Thr-68 Chk2 (2197; Cell Signaling), anti-p16INK4a (mouse mAb 11104; Immuno-Biological Laboratories, Minneapolis, MN), and PRC1 antibody described previously ([@B47]).

Cell proliferation assay
------------------------

After treatment with DCB for 24 h and release, HCT116 cells were suspended at the times indicated in a precise volume and an aliquot placed on a calibrated slide. Viable cells, identified by trypan blue exclusion, were counted in phase contrast.

γ-Irradiation
-------------

Randomly cycling REF52 and TAG cells received 4 Gy, using a ^137^Cs γ-irradiator at 2 Gy/min, and then were processed for IF using anti-γ-H2AX antibody, DAPI stain, and IF procedures described earlier.

Lentivirus production and infection of HFF
------------------------------------------

Lentiviral particles were obtained by transfecting human embryonic kidney HEK293 cells (seeded in 15-cm dishes) using FUCCI lentiviral constructs (L-CDT and L-GMN), as described earlier ([@B63]). To infect HFF cells, 5 × 10^3^ cells were seeded on four- or eight-well chambered glass slides, coated with fibronectin, and incubated with 1 ml of each viral supernatant in the presence of Polybrene, 10 μg/ml. After 24 h of incubation with lentivirus, fresh medium with or without 10 μM DCB was added, and cells were seeded onto four- or eight-well chambered glass slides, where they were subjected to live-cell imaging with a DeltaVision deconvolution microscopy unit.
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